Labcorp expands automated clinical trial kit production line at european operations center

Burlington, n.c.--(business wire)--labcorp® (nyse: lh), a leading global life sciences company, today announced an expansion of its automated clinical trial kit production line in mechelen, belgium. once completed, expansion will allow for clinical trial test kits to be fulfilled in mechelen for more than 70 countries throughout europe, the middle east and africa (emea). this is up from 27 countries in 2021. the company's industry-leading central laboratory services unit is part of labcorp drug
LH Ratings Summary
LH Quant Ranking